Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma (Q35653813)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 November 2011
edit
Language Label Description Also known as
English
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
scientific article published on 29 November 2011

    Statements

    Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit